Overview
Matthew Robinson, MD, is Assistant Professor in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. He is interested in leveraging diagnostic innovation and precision medicine to reduce diagnostic and prognostic uncertainty for infectious diseases. His current projects include applications in global health, antimicrobial resistance, antibiotic stewardship, infection control, COVID-19, acute febrile illness, and tuberculosis. After undergraduate and medical school at Northwestern University, he completed internal medicine residency at New York University and Infectious Diseases fellowship at Johns Hopkins School of Medicine. During medical school, he worked at the Chinese Center for Disease Control and Prevention in Beijing, China under a Doris Duke International Clinical Research Fellowship. He also served as a clinician educator in internal medicine in Gulu, Uganda at the Gulu University Faculty of Medicine as a Global Health Service Partnership volunteer. As a fellow, he pursued a Fogarty Global Health Fellowship in Pune, India and an Antibacterial Resistance Leadership Group Fellowship. Since joining the faculty in 2019, Dr. Robinson has been supported by the Centers for Disease Control and Prevention, National Institutes of Health, and Food and Drug Administration. The focus of his work in antimicrobial resistance, antibiotic stewardship, infection control has been to characterize drug-resistant Gram-negative infections in India. His work with the Johns Hopkins Precision Medicine Center of Excellence for COVID-19 has included applying machine learning and causal inference techniques to predict COVID-19 outcomes. He has contributed to SARS-CoV-2 diagnostic development through the NIH Rapid Acceleration of Diagnostics (RADx) initiative and through collaborative development of other novel diagnostics.
Dr. Robinson is rated as an Experienced provider by MediFind in the treatment of Dengue Fever. His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Togaviridae Disease, and Dengue Fever.
His clinical research consists of co-authoring 76 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Dengue Fever.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is rated as a Distinguished provider by MediFind in the treatment of Dengue Fever. Her top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever.
University Of Maryland Physicians PA
Joel Chua is an Infectious Disease provider in Baltimore, Maryland. Dr. Chua is rated as an Advanced provider by MediFind in the treatment of Dengue Fever. His top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Hepatitis, and Osteomyelitis.
University Of Maryland Physicians PA
Kirsten Lyke is an Infectious Disease provider in Baltimore, Maryland. Dr. Lyke is rated as a Distinguished provider by MediFind in the treatment of Dengue Fever. Her top areas of expertise are Malaria, Primary Amebic Meningoencephalitis, Rabies, and Viral Hemorrhagic Fever.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Dr. Robinson isAdvanced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)
- Togaviridae DiseaseDr. Robinson isAdvanced. Learn about Togaviridae Disease.
- Experienced
- Bacterial MeningitisDr. Robinson isExperienced. Learn about Bacterial Meningitis.
- ChikungunyaDr. Robinson isExperienced. Learn about Chikungunya.
- Dengue FeverDr. Robinson isExperienced. Learn about Dengue Fever.
- HIV/AIDSDr. Robinson isExperienced. Learn about HIV/AIDS.
- MalariaDr. Robinson isExperienced. Learn about Malaria.
- MeningitisDr. Robinson isExperienced. Learn about Meningitis.